Episurf Medical AB Series B
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more
Episurf Medical AB Series B (0QUT) - Total Assets
Latest total assets as of September 2021: Skr134.60 Million SEK
Based on the latest financial reports, Episurf Medical AB Series B (0QUT) holds total assets worth Skr134.60 Million SEK as of September 2021.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Episurf Medical AB Series B - Total Assets Trend (2018–2020)
This chart illustrates how Episurf Medical AB Series B’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Episurf Medical AB Series B - Asset Composition Analysis
Current Asset Composition (December 2020)
Episurf Medical AB Series B's total assets of Skr134.60 Million consist of 86.5% current assets and 13.5% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0.0% |
| Accounts Receivable | Skr3.00 Million | 1.6% |
| Inventory | Skr2.00 Million | 1.1% |
| Property, Plant & Equipment | Skr3.80 Million | 2.1% |
| Intangible Assets | Skr20.80 Million | 11.2% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2018–2020)
This chart illustrates how Episurf Medical AB Series B's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Episurf Medical AB Series B's current assets represent 86.5% of total assets in 2020, an increase from 61.3% in 2018.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2020, the same as 0.0% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 38.0% in 2018.
- Asset Diversification: The largest asset category is intangible assets at 11.2% of total assets.
Episurf Medical AB Series B Competitors by Total Assets
Key competitors of Episurf Medical AB Series B based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
| No similar companies found. | ||
Episurf Medical AB Series B - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Episurf Medical AB Series B generates 0.04x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Episurf Medical AB Series B is currently not profitable relative to its asset base.
Episurf Medical AB Series B - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 17.98 | 10.95 | 11.17 |
| Quick Ratio | 17.85 | 10.81 | 11.00 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr210.60 Million | Skr 130.30 Million | Skr 114.90 Million |
Episurf Medical AB Series B - Advanced Valuation Insights
This section examines the relationship between Episurf Medical AB Series B's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 221.9% |
| Total Assets | Skr185.40 Million |
| Market Capitalization | $6.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Episurf Medical AB Series B's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Episurf Medical AB Series B's assets grew by 221.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Episurf Medical AB Series B (2018–2020)
The table below shows the annual total assets of Episurf Medical AB Series B from 2018 to 2020.
| Year | Total Assets | Change |
|---|---|---|
| 2020-12-31 | Skr185.40 Million | +221.88% |
| 2019-12-31 | Skr57.60 Million | +5.11% |
| 2018-12-31 | Skr54.80 Million | -- |